Search Results - "Penna Lima, Tathiane Regine"
-
1
Association between genetic polymorphisms in DNA mismatch repair‐related genes with risk and prognosis of head and neck squamous cell carcinoma
Published in International journal of cancer (15-08-2015)“…We examined the influence of MLH1 c.−93G>A, MSH2 c.211 + 9C>G, MSH3 c.3133G>A and EXO1 c.1765G>A polymorphisms, involved in DNA mismatch repair (MMR), on head…”
Get full text
Journal Article -
2
CASP9 c.‐1339A>G and CASP3 c.‐1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma
Published in Head & neck (01-08-2019)“…Background Single nucleotide polymorphisms (SNPs) in genes that act in intrinsic apoptosis pathway may modulate cancer susceptibility. This study investigated…”
Get full text
Journal Article -
3
Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients
Published in Oncotarget (03-07-2018)“…Head and neck squamous cell carcinoma (HNSCC) is treated with cisplatin (CDDP) and radiotherapy (RT), and distinct results are observed among patients with…”
Get full text
Journal Article -
4
XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation
Published in Oncotarget (07-03-2017)“…This study aimed to investigate the associations of XPC c.2815A>C, XPD c.934G>A and c.2251A>C, XPF c.2505T>C and ERCC1 c.354C>T single nucleotide polymorphisms…”
Get full text
Journal Article -
5
FAS and FASL variations in outcomes of tobacco- and alcohol-related head and neck squamous cell carcinoma patients
Published in Tumor biology (01-07-2020)“…Radiotherapy and cisplatin lead to cell killing in head and neck squamous cell carcinoma patients, but adverse events and response to treatment are not the…”
Get full text
Journal Article -
6
Do Genetic Polymorphisms Modulate Response Rate and Toxicity of Cisplatin Associated With Radiotherapy in Laryngeal Squamous Cell Carcinoma?: A Case Report
Published in Medicine (Baltimore) (01-04-2015)“…Cisplatin (CDDP) plus radiotherapy (RT) has been used to treat advanced laryngeal squamous cell carcinoma (LSCC) patients. Single nucleotide polymorphisms…”
Get full text
Journal Article -
7
Association of FASL and FAS polymorphisms, enrolled in extrinsic apoptosis pathway, with head and neck squamous cell carcinoma risk and outcomes
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
8
GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.‐1339A>G Polymorphisms and Severity of Vomiting in Head and Neck Cancer Patients treated with Cisplatin Chemoradiation
Published in Basic & clinical pharmacology & toxicology (01-12-2017)“…Cisplatin (CDDP) chemotherapy associated with radiation (RT) has been used in advanced head and neck squamous cell carcinoma (HNSCC) patients, and vomiting is…”
Get full text
Journal Article -
9
GSTP 1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP 9 c.‐1339A>G Polymorphisms and Severity of Vomiting in Head and Neck Cancer Patients treated with Cisplatin Chemoradiation
Published in Basic & clinical pharmacology & toxicology (01-12-2017)“…Cisplatin ( CDDP ) chemotherapy associated with radiation ( RT ) has been used in advanced head and neck squamous cell carcinoma ( HNSCC ) patients, and…”
Get full text
Journal Article -
10
MLH1 , MSH2 , MSH3 and EXO1 polymorphisms and head and neck squamous cell carcinoma risk and prognosis
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
11
-
12
and variations in outcomes of tobacco- and alcohol-related head and neck squamous cell carcinoma patients
Published in Tumor biology (01-07-2020)“…Radiotherapy and cisplatin lead to cell killing in head and neck squamous cell carcinoma patients, but adverse events and response to treatment are not the…”
Get full text
Journal Article